Search Results for: asset management company

Gilead's Remdesivir authorised for emergency use only

COVID-19 drug Remdesivir's price in India is a concern; Pharma cos free to set price

Gilead Sciences' signs non-exclusive license pact with four Indian drug majors to set their own price for Covid-19 drug Remdesivir. Following this move, many pharma distributors have been selling the experimental drug at Rs 7000 per vial. This will result in escalated treatment cost, to procure vials approximating to Rs 35,000 to Rs 42,000 for five doses. Jun 5, 2020
Prev 441 442 443 444 445 446 447 448 449 450 Next